Trofinetide Completed Phase 2 Trials for Fragile X Syndrome (FXS) Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT01894958 | A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome |
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT01894958 | A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome |